404 related articles for article (PubMed ID: 19485966)
1. Expression of p16(INK4a) in peripheral blood T-cells is a biomarker of human aging.
Liu Y; Sanoff HK; Cho H; Burd CE; Torrice C; Ibrahim JG; Thomas NE; Sharpless NE
Aging Cell; 2009 Aug; 8(4):439-48. PubMed ID: 19485966
[TBL] [Abstract][Full Text] [Related]
2. Effect of cytotoxic chemotherapy on markers of molecular age in patients with breast cancer.
Sanoff HK; Deal AM; Krishnamurthy J; Torrice C; Dillon P; Sorrentino J; Ibrahim JG; Jolly TA; Williams G; Carey LA; Drobish A; Gordon BB; Alston S; Hurria A; Kleinhans K; Rudolph KL; Sharpless NE; Muss HB
J Natl Cancer Inst; 2014 Apr; 106(4):dju057. PubMed ID: 24681605
[TBL] [Abstract][Full Text] [Related]
3. Role of senescence marker p16 INK4a measured in peripheral blood T-lymphocytes in predicting length of hospital stay after coronary artery bypass surgery in older adults.
Pustavoitau A; Barodka V; Sharpless NE; Torrice C; Nyhan D; Berkowitz DE; Shah AS; Bandeen Roche KJ; Walston JD
Exp Gerontol; 2016 Feb; 74():29-36. PubMed ID: 26692418
[TBL] [Abstract][Full Text] [Related]
4. Expression of p16(INK4a) as a biomarker of T-cell aging in HIV-infected patients prior to and during antiretroviral therapy.
Nelson JA; Krishnamurthy J; Menezes P; Liu Y; Hudgens MG; Sharpless NE; Eron JJ
Aging Cell; 2012 Oct; 11(5):916-8. PubMed ID: 22738669
[TBL] [Abstract][Full Text] [Related]
5. A quantitative model for age-dependent expression of the p16INK4a tumor suppressor.
Tsygankov D; Liu Y; Sanoff HK; Sharpless NE; Elston TC
Proc Natl Acad Sci U S A; 2009 Sep; 106(39):16562-7. PubMed ID: 19805338
[TBL] [Abstract][Full Text] [Related]
6. The regulation of INK4/ARF in cancer and aging.
Kim WY; Sharpless NE
Cell; 2006 Oct; 127(2):265-75. PubMed ID: 17055429
[TBL] [Abstract][Full Text] [Related]
7. Accelerated aging among childhood, adolescent, and young adult cancer survivors is evidenced by increased expression of p16
Smitherman AB; Wood WA; Mitin N; Ayer Miller VL; Deal AM; Davis IJ; Blatt J; Gold SH; Muss HB
Cancer; 2020 Nov; 126(22):4975-4983. PubMed ID: 32830315
[TBL] [Abstract][Full Text] [Related]
8. Determining the relationship of p16
Rosko AE; Elsaid MI; Woyach J; Islam N; Lepola N; Urrutia J; Christian LM; Presley C; Mims A; Burd CE
J Cancer Surviv; 2024 Apr; ():. PubMed ID: 38678524
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of the INK4a/ARF locus in polycythemia vera.
Dai C; Krantz SB
Blood; 2001 Jun; 97(11):3424-32. PubMed ID: 11369633
[TBL] [Abstract][Full Text] [Related]
10. Ubiquitin-mediated protein degradation and methylation-induced gene silencing cooperate in the inactivation of the INK4/ARF locus in Burkitt lymphoma cell lines.
Roberti A; Rizzolio F; Lucchetti C; de Leval L; Giordano A
Cell Cycle; 2011 Jan; 10(1):127-34. PubMed ID: 21200153
[TBL] [Abstract][Full Text] [Related]
11. Ink4a/Arf expression is a biomarker of aging.
Krishnamurthy J; Torrice C; Ramsey MR; Kovalev GI; Al-Regaiey K; Su L; Sharpless NE
J Clin Invest; 2004 Nov; 114(9):1299-307. PubMed ID: 15520862
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy and Stem Cell Transplantation Increase p16
Wood WA; Krishnamurthy J; Mitin N; Torrice C; Parker JS; Snavely AC; Shea TC; Serody JS; Sharpless NE
EBioMedicine; 2016 Sep; 11():227-238. PubMed ID: 27591832
[TBL] [Abstract][Full Text] [Related]
13. The inhibitor of cyclin-dependent kinase 4a/alternative reading frame (INK4a/ARF) locus encoded proteins p16INK4a and p19ARF repress cyclin D1 transcription through distinct cis elements.
D'Amico M; Wu K; Fu M; Rao M; Albanese C; Russell RG; Lian H; Bregman D; White MA; Pestell RG
Cancer Res; 2004 Jun; 64(12):4122-30. PubMed ID: 15205322
[TBL] [Abstract][Full Text] [Related]
14. Immunosenescence profile and expression of the aging biomarker (p16
Bourlon MT; Velazquez HE; Hinojosa J; Orozco L; Rios-Corzo R; Lima G; Llorente L; Hernandez-Ramirez DF; Valentin-Cortez FJ; Medina-Rangel I; Atisha-Fregoso Y
BMC Cancer; 2020 Sep; 20(1):882. PubMed ID: 32928147
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of p14ARF, p15INK4b, and p16INK4a inactivation in malignant peripheral nerve sheath tumors.
Endo M; Kobayashi C; Setsu N; Takahashi Y; Kohashi K; Yamamoto H; Tamiya S; Matsuda S; Iwamoto Y; Tsuneyoshi M; Oda Y
Clin Cancer Res; 2011 Jun; 17(11):3771-82. PubMed ID: 21262917
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of p19(Arf) and p16(Ink4a) loss on senescence of murine bone marrow-derived preB cells and macrophages.
Randle DH; Zindy F; Sherr CJ; Roussel MF
Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9654-9. PubMed ID: 11481442
[TBL] [Abstract][Full Text] [Related]
17. Expression of Chr9p21 genes CDKN2B (p15(INK4b)), CDKN2A (p16(INK4a), p14(ARF)) and MTAP in human atherosclerotic plaque.
Holdt LM; Sass K; Gäbel G; Bergert H; Thiery J; Teupser D
Atherosclerosis; 2011 Feb; 214(2):264-70. PubMed ID: 20637465
[TBL] [Abstract][Full Text] [Related]
18. INK4 locus of the tumor-resistant rodent, the naked mole rat, expresses a functional p15/p16 hybrid isoform.
Tian X; Azpurua J; Ke Z; Augereau A; Zhang ZD; Vijg J; Gladyshev VN; Gorbunova V; Seluanov A
Proc Natl Acad Sci U S A; 2015 Jan; 112(4):1053-8. PubMed ID: 25550505
[TBL] [Abstract][Full Text] [Related]
19. Definition of three minimal deleted regions by comprehensive allelotyping and mutational screening of FHIT,p16(INK4A), and p19(ARF) genes in nasopharyngeal carcinoma.
Ko JY; Lee TC; Hsiao CF; Lin GL; Yen SH; Chen KY; Hsiung CA; Chen PJ; Hsu MM; Jou YS
Cancer; 2002 Apr; 94(7):1987-96. PubMed ID: 11932901
[TBL] [Abstract][Full Text] [Related]
20. Recovery of function in osteoarthritic chondrocytes induced by p16INK4a-specific siRNA in vitro.
Zhou HW; Lou SQ; Zhang K
Rheumatology (Oxford); 2004 May; 43(5):555-68. PubMed ID: 15026580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
